Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancer

Prognostic and predictive value of a lncRNA signature in patients with stage II colon cancer

Abstract The current staging method is inadequate to identify high-risk recurrence patients with stage II colon cancer (CC). Using a systematic and comprehensive-biomarker discovery and validation method, we aimed to construct a lncRNA-based signature to improve the prognostic prediction of stage II...

Full description

Bibliographic Details
Main Authors: Ailin Qu, Qian Wang, Qing Chang, Jingkang Liu, Yongmei Yang, Xin Zhang, Yanli Zhang, Xiaoshi Zhang, Hongchun Wang, Yi Zhang
Format: Article
Language:English
Published: Nature Portfolio 2023-01-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-022-25852-5

Internet

https://doi.org/10.1038/s41598-022-25852-5

Similar Items